• RacMartha W FMWF0000-0002-0673-8845Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA., Irene A Stafford, and Catherine S Eppes.
• Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.
• Prenat. Diagn. 2020 Dec 1; 40 (13): 1703-1714.

AbstractCongenital syphilis (CS) rates reached a 20-year high in the United States in 2018. Unlike previous years, most babies diagnosed with CS were born to mothers who received prenatal care, indicative of the need for better provider education and guideline adherence. Current rates suggest that screening for syphilis should be performed at the first prenatal care visit and twice during the third trimester. There are two diagnostic algorithms available for use in the United States (traditional and reverse) and providers must understand how to perform each algorithm. Treatment should be administered according to stage of syphilis per Centers for Disease Control recommendations with best neonatal outcomes seen when treatment is initiated >30 days before delivery. Benzathine Penicillin G remains the only recommended treatment of syphilis during pregnancy. In viable pregnancies, a pretreatment ultrasound is recommended to identify sonographic evidence of fetal infection and treatment should be initiated with continuous fetal monitoring to evaluate for the Jarisch-Herxheimer reaction which can cause preterm labor and fetal distress. After adequate syphilotherapy, a fourfold decline in maternal nontreponemal titers may not be observed by delivery and does not correlate with rates of CS.© 2020 John Wiley & Sons, Ltd.

29 keywords...

hide…